Keyphrases
Systemic Treatment
100%
Treatment Toxicity
100%
Systemic Chemotherapy
66%
Localized Delivery
66%
Entrapment
66%
Metastasis
50%
Local Delivery
50%
Breast Cancer Patients
50%
Breast Cancer
33%
Translational Studies
33%
Metastatic Breast Cancer
33%
Triple-negative Breast Cancer
33%
Preclinical in Vivo Models
33%
Breast Cancer Survivors
33%
Tumor Environment
33%
Injectable Drug Delivery
33%
Independent Mode
33%
Preclinical in Vitro Models
33%
Tumor Eradication
33%
Tumor Regression
33%
System Flexibility
33%
Locoregional
33%
Thermoresponsive
33%
Local Chemotherapy
33%
Clinical Trails
33%
Surgical Margin
33%
Surgical Tissues
33%
Breast Cancer Burden
33%
Early Breast Cancer
33%
Antitumor Drug Delivery
33%
Breast Lesions
33%
Cancer Growth
16%
Therapeutic Potential
16%
Strong Potential
16%
Tumor Recurrence
16%
Local Treatment
16%
Molecular Study
16%
Chemotherapy
16%
Drug Delivery System
16%
Targeted Therapy
16%
Tumor-associated
16%
Stiffness
16%
Clinical Trials
16%
Medical Intervention
16%
Drug Delivery
16%
Racial Groups
16%
Extracellular Matrix
16%
Preventive Screening
16%
Ethnic Groups
16%
Controlled Release
16%
Underrepresented Students
16%
Lifesaving
16%
High Prevalence
16%
African American Women
16%
Potential Impact
16%
Biomedical Research
16%
Multidisciplinary Study
16%
Systemic Toxicity
16%
Primary Tumor
16%
Covalent Linkage
16%
Tumor Site
16%
Obesity
16%
Breast Cancer Mortality
16%
Cell Death
16%
Research Training
16%
Therapeutic Agents
16%
Surrounding Tissues
16%
Tumor Metastasis
16%
Drug Candidates
16%
Medicine and Dentistry
Systemic Therapy
100%
Breast Cancer
50%
Metastatic Carcinoma
50%
Neoplasm
20%
Chemotherapy
15%
Controlled Release
10%
Breast Lesion
10%
Tumor Regression
10%
Biological Product
10%
Surgical Margin
10%
Triple Negative Breast Cancer
10%
Targeted Therapy
5%
Medical Intervention
5%
Tumor Recurrence
5%
Gene Linkage
5%
Ethnic Group
5%
Clinical Trial
5%
Flexibility
5%
Drug Delivery System
5%
Disease
5%
Local Therapy
5%
Biomedical Research
5%
Prevalence
5%
Extracellular Matrix
5%
Therapeutic Agent
5%
Cancer Growth
5%
Cancer Mortality
5%
Hope
5%
Racial Group
5%
Primary Tumor
5%
In Vitro
5%
Cell Death
5%
Pharmacology, Toxicology and Pharmaceutical Science
Systemic Treatment
100%
Breast Cancer
50%
Neoplasm
20%
Chemotherapy
20%
Metastasis
15%
Biological Product
10%
Breast Lesion
10%
Tumor Regression
10%
Triple Negative Breast Cancer
10%
Drug Delivery System
5%
Prevalence
5%
Controlled Release
5%
Tumor Recurrence
5%
Clinical Trial
5%
Disease
5%
Cancer Growth
5%
Cancer Mortality
5%
Primary Tumor
5%